Cassava Sciences, Inc.
Cassava Sciences, Inc. (SAVA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · SAVA · as of Jun 9, 2026
Key Statistics
Explore Cassava Sciences, Inc. Data
sava stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 66.7%
Competitors & Peers
sava competitorsSAVA
ALEC
CRDF
CYBN
ELTX
FATEStock Performance
Full HistoryAbout Cassava Sciences, Inc.
Cassava Sciences, Inc. is a biopharmaceutical enterprise in the clinical development phase, specializing in the creation of treatments for neurodegenerative disorders. The company's primary experiment…
what is cassava sciences, inc. · sava stock overview · cassava sciences, inc. company profile · who is cassava sciences, inc. ceo · sava NASDAQ · cassava sciences, inc. headquarters · cassava sciences, inc. business segments
About Stock Overview & Key Data
Cassava Sciences, Inc. (SAVA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 14, 2000. As of the latest trading session, SAVA stock price is $1.32, with a market capitalization of $63.8M. The stock has returned -38.60% over the past 12 months and -33.33% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Cassava Sciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cassava Sciences, Inc. reported revenue of — and net income of -$91.0M. For detailed data — including Cassava Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cassava Sciences, Inc. (SAVA) stock price is $1.32. The stock is traded on NASDAQ under the ticker symbol SAVA. The 52-week range is $1.15 – $4.98.